Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TREAT-GNB [CR-GNB]

NCT07004049 is registered in ClinicalTrials.gov with National University of Singapore as lead sponsor.

NCT NCT07004049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TREAT-GNB [CR-GNB]
Lead sponsor
National University of Singapore
Phase
Phase 4
Overall status
Recruiting
Start date
April 21, 2025
Completion date
December 31, 2028
Enrollment
600 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection, carbapenem resistant bacterial infection, hospital acquired bacterial pneumonia, multidrug resistance, ventilator associated bacterial pneumonia